Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
23 April 2020updated 06 Oct 2020 9:45am

Government launches mass coronavirus study that will test 300,000 people at home

By Samuel Horti

The government has today announced a mass coronavirus testing study that will eventually recruit 300,000 people across the UK.

The study, which will start with a pilot of 25,000 people, will ask participants to swab their nose and throat and answer questions from a health worker who will visit their home. The study will test whether someone has the virus, and the government will separately ask adults from 1,000 households to provide a blood sample, taken by a trained nurse, phlebotomist or healthcare assistant, to determine whether they have developed antibodies to Covid-19.

They will be asked to take a test every week for the first five weeks of the study, then every month for 12 months. People will take the swab tests whether they have symptoms of coronavirus or not. Those asked to take part will be contacted shortly and will form a representative sample of the UK population by age and geography.

The results will help scientists and ministers better understand the spread of the virus and make decisions about easing the lockdown. Initial findings are expected in early May. The study, led by the Department for Health and Social Care (DHSC) and the Office for National Statistics (ONS), will eventually recruit up to around 300,000 people over the next 12 months.

Health Secretary Matt Hancock said: “This survey will help to track the current extent of transmission and infection in the UK, while also answering crucial questions about immunity as we continue to build up our understanding of this new virus.

Select and enter your email address Quick and essential guide to domestic and global politics from the New Statesman's politics team. A weekly newsletter helping you fit together the pieces of the global economic slowdown. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s weekly environment email on the politics, business and culture of the climate and nature crises - in your inbox every Thursday. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A newsletter showcasing the finest writing from the ideas section and the NS archive, covering political ideas, philosophy, criticism and intellectual history - sent every Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
  • Administration / Office
  • Arts and Culture
  • Board Member
  • Business / Corporate Services
  • Client / Customer Services
  • Communications
  • Construction, Works, Engineering
  • Education, Curriculum and Teaching
  • Environment, Conservation and NRM
  • Facility / Grounds Management and Maintenance
  • Finance Management
  • Health - Medical and Nursing Management
  • HR, Training and Organisational Development
  • Information and Communications Technology
  • Information Services, Statistics, Records, Archives
  • Infrastructure Management - Transport, Utilities
  • Legal Officers and Practitioners
  • Librarians and Library Management
  • Management
  • Marketing
  • OH&S, Risk Management
  • Operations Management
  • Planning, Policy, Strategy
  • Printing, Design, Publishing, Web
  • Projects, Programs and Advisors
  • Property, Assets and Fleet Management
  • Public Relations and Media
  • Purchasing and Procurement
  • Quality Management
  • Science and Technical Research and Development
  • Security and Law Enforcement
  • Service Delivery
  • Sport and Recreation
  • Travel, Accommodation, Tourism
  • Wellbeing, Community / Social Services
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

“Together, these results will help us better understand the spread of the virus to date, predict the future trajectory and inform future action we take, including crucially the development of ground-breaking new tests and treatments.”